2015 Antineoplastics
Overview
|
Cancer treatment
|
General Concepts
|
Prevent DNA synthesis
|
Disrupt DNA
|
Antimitotics
|
Immune System Modulators
|
Target Proteins
|
Angiogenesis Inhibitors
|
Differentiating Agents
|
Interfere with Hormone Function
|
Treatment Strategies
|
Breast cancer treatment
Angiogenesis Inhibitors
/
Thalidomide
/ Pharmacokinetics
DRUGS THAT INTEREFERE WITH ANGIOGENESIS:
THALIDOMIDE
Pharmacokinetics
oral
breakdown products are rapidly excreted via renal elimination
search
Drug cards
Types of Antiangiogenics
Interleukin 12
Interferon α
Role of VEGF and mTOR
VEGF & VEGF-R inhibitors
Bevacizumab
VEGF-R-inhibiting STIs
mTOR inhibitors
Mechanism
Pharmacokinetics
Therapeutic uses
Toxcity
Thalidomide
Mechanism of action
Pharmacokinetics
Therapeutic uses
Toxicity
Phocomelia
Email: Dr. Janet Fitzakerley
| ©2015 University of Minnesota Medical School Duluth | Last modified: 11-apr-15 9:39 AM